Patients without obstructive stenosis in whom complicated carotid plaques are detected on MRI in the early days after an ischemic stroke or TIA are at increased risk for a recurrent cerebrovascular ...
Bayer’s investigational, once-daily, oral Factor XIa inhibitor asundexian reduced the risk of recurrent ischemic stroke by 26% in a pivotal trial. In the Phase III OCEANIC-STROKE study (NCT05686070), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results